ArticleFrontiers in neurology2024

Evolocumab for early reduction of LDL-C levels in patients with acute ischemic stroke: a randomized controlled trial.

Xiaohui Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.